Position in JAZZ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$70,056,003
+$20,420,359 QoQ
Shares Held
290,725
+10.7% QoQ
Ownership
0.448%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#44
of 643 holders
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JAZZ Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Qube Research & Technologies Ltd holds $2,443,042,063 across 169 Biotechnology names. JAZZ ranks #9 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
798,715 | $240,437,176 | |
| 2 | INSM |
INSMED Inc
|
1,682,334 | $179,370,451 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
221,607 | $138,180,828 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
3,454,496 | $122,254,613 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
426,336 | $104,354,262 | |
| 6 | APGE |
Apogee Therapeutics, Inc.
|
659,678 | $87,559,060 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,443,230 | $81,989,896 | |
| 8 | RPRX |
Royalty Pharma plc
|
1,412,112 | $79,177,119 |
All Filings in JAZZ
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $70,056,003 | 290,725 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $49,635,644 | 262,553 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $85,082,620 | 500,486 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $7,412,959 | 56,244 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $13,076,318 | 123,222 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $40,655,276 | 327,469 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $6,821,278 | 55,390 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $11,068,694 | 99,351 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $608,361 | 5,700 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $9,453,090 | 78,501 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $45,231,405 | 367,735 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $37,741,856 | 291,578 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $48,209,081 | 388,877 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $14,966,193 | 102,277 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $11,521,139 | 72,319 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $12,839,025 | 96,324 | Shares | Sole | 2022-11-14 | |
| 2021-12-31 | $3,703,772 | 29,072 | Shares | Sole | 2022-02-10 | |
| 2021-06-30 | $884,291 | 4,978 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $5,719,911 | 34,799 | Shares | Sole | 2021-05-14 | |
| 2020-06-30 | $1,221,574 | 11,071 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $1,137,833 | 11,408 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||